Expert consensus on BRCA1/2 gene testing and clinical application in Chinese breast cancer patients (2025 edition)
Breast cancer remains one of the frequently diagnosed malignant tumors among Chinese women, with hereditary cases accounting for 5%-10% of all diagnoses, where BRCA1/2 gene mutations serve as the primary genetic predisposition factors. Although targeted therapies like poly (ADP-ribose) polymerase (P...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Office of China Oncology
2025-07-01
|
| Series: | Zhongguo aizheng zazhi |
| Subjects: | |
| Online Access: | https://www.china-oncology.com/fileup/1007-3639/PDF/1755061437231-1222886985.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|